跳至主要内容
临床试验/EUCTR2016-000160-42-AT
EUCTR2016-000160-42-AT进行中(未招募)1 期

Effect of inhaled budenoside on the incidence and severity of Acute Mountain Sickness at 4559 m - Inhaled budenoside and AMS

K für Anästhesiologie und allgemeine Intensivmedizin0 个研究点目标入组 51 人开始时间: 2016年3月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Age 18-60 years
  • -Good physical condition
  • -No relevant pathologies upon the pre-examination prior to the study
  • -Written informed consent to participate in the study
  • -Males and females are included without prioritization
  • -Permanent residency below 1000 m
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 51
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Acute and chronic lung diseases
  • -Conventional systolic blood pressure (average of two measurements) =150 mmHg and conventional diastolic blood pressure =95 mmHg in untreated or treated subjects Cardiovascular diseases other than hypertension (coronary heart disease, heart failure, atrial fibrillation, peripheral artery disease)
  • -Chronic headache / migraine
  • -Diabetes mellitus
  • -Smoking (>6 cigarettes/day) or equivalent nicotine substitutes
  • -Alcohol (>30 g/d) or drug abuse
  • -Obesity (Body Mass Index >30)
  • -Other conditions deemed relevant by the investigator (including liver disease, renal disease, thyroid disorders)
  • -Sojourn >2000 m within the last 4 weeks before the 1st study day
  • -Drug intake within the last 2 moth before the 1st study day if the drug intake could affect the data quality (eg. corticosteroids) or the safety of the participants (eg. anti- coagulants)
  • -Blood donation within the last 2 month before the 1st study day

研究者

发起方
K für Anästhesiologie und allgemeine Intensivmedizin

相似试验